ContraFect competitorsClear all

ContraFect's top competitors include TxCell and Sovicell.
ContraFect
ContraFect
ContraFect is a biotechnology company focused on developing treatments for drug-resistant, life-threatening infectious diseases.
TxCell
TxCell
TxCell develops cellular immunotherapy platforms based on antigen-specific regulatory T cells.
Sovicell
Sovicell
Sovicell is a company that specializes in providing ADMET (absorption, distribution, metabolism, excretion, and toxicity) products and services.
Founding Date
Founding Date
2008
Founding Date
2001
Founding Date
1994
Type
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Yonkers, US HQ
Locations
Valbonne, FR HQ
Locations
Leipzig, DE HQ
Employees
Employees
2420% increase
Employees
205% decrease
Employees
2
Employee Rating
Employee Rating
2.5
Employee Rating
1
Employee Rating
N/A

Financial

Net income
Net income
($12.8m) (FY, 2019)
Net income
(€10.9m) (FY, 2017)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 71.6m
Total funding raised
$ 1.2m
For sources of this data, please see the company profile

View company profiles

TxCell
HQ
Valbonne, FR

TxCell develops cellular immunotherapy platforms based on antigen-specific regulatory T cells.

View company
Sovicell
HQ
Leipzig, DE
Employees
2

Sovicell is a company that specializes in providing ADMET (absorption, distribution, metabolism, excretion, and toxicity) products and services.

View company